Ohio med-device start-ups win grants

May 24, 2010 by MedCity News

Fluence Therapeutics Inc. and Dysphagia each land a $25,000 grant to develop a drug/device combination for psoriasis and a neurostimulation device for the eponymous swallowing disorder, respectively.

MedCity News logo

By Mary Vanac

Two northeast Ohio start-ups that are developing treatments for psoriasis and for people who have trouble swallowing are getting $25,000 grants from the Innovation Fund of the Lorain County Community College Foundation.

Fluence Therapeutics Inc. of Akron, which has licensed photodynamic therapy technology from University Hospitals Case Medical Center in Cleveland, is developing both a drug and a medical device to treat psoriasis. The company will use its grant for three things, CEO Warren Goldenberg said.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.